Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2016

Jul 6, 2016

34975_dirs_2016-07-06_c02593b8-77cd-4556-807b-745ecd86271b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2016-07-01

Reporting Person: GREEN DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-07-01 Common Stock A 25300 $0.00 Acquired 530210 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 322124 Indirect
Common Stock 300000 Indirect

Footnotes

F1: Represents a deferred stock award of 25,300 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017.

F2: Includes (a) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; (b) a deferred stock award of 5,150 restricted stock units which vest quarterly in equal installments on September 30, 2016 and December 31, 2016; and (c) 499,760 shares of common stock held by the Reporting Person.